Cushing's Syndrome: Tirzepatide
Commons · Question 39223 · Tabled 18 Mar 2025 · Department of Health and Social Care · Official record
Answered 26 Mar 2025
Question
Asked by Charlotte Cane
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of prescribing Mounjaro for Cushing's syndrome on the NHS.
Answer
Answered by Karin Smyth, 26 Mar 2025
The Department has made no assessment. Mounjaro is not licensed as a treatment option for Cushing’s syndrome. The National Institute for Health and Care Excellence (NICE) would consider an evaluation of Mounjaro for Cushing’s syndrome if the company, Eli ...